| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:10:03 UTC |
|---|
| Update date | 2025-11-18 23:35:03 UTC |
|---|
| Primary ID | FDB012223 |
|---|
| Secondary Accession Numbers | |
|---|
| Chemical Information |
|---|
| FooDB Name | Biochanin A |
|---|
| Description | Widespread isoflavone found in alfalfa (Medicago sativa), chick peas (Cicer arietinum) and white clover (Trifolium repens). Glycosides also widespread. Potential nutriceutical
The phytoestrogen biochanin A is an isoflavone derivative isolated from red clover Trifolium pratense with anticarcinogenic properties. Treating MCF-7 human breast carcinoma cells with biochanin A alone caused the accumulation of CYP1A1 mRNA and an increase in CYP1A1-specific 7-ethoxyresorufin O-deethylase (EROD) activity in a dose dependent manner. Biochanin A may be a natural ligand to bind on aryl hydrocarbon receptor acting as an antagonist/agonist of the pathway. (PMID: 16903077); Biochanin A suppress nuclear factor-kappaB-driven interleukin-6 (IL6) expression. In addition to its physiologic immune function as an acute stress cytokine, sustained elevated expression levels of IL6 promote chronic inflammatory disorders, aging frailty, and tumorigenesis. (PMID: 16651441); Biochanin A induces a decrease in invasive activity of U87MG cells in a dose-related manner. (PMID: 16598420); Biochanin A activates peroxisome proliferator-activated receptors (PPAR) PPARalpha, PPARgamma, and adipocyte differentiation in vitro of 3T3-L1 preadipocytes, suggesting potential value of isoflavones, especially biochanin A and their parent botanicals, as antidiabetic agents and for use in regulating lipid metabolism. (PMID: 16549448). |
|---|
| CAS Number | 491-80-5 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 4'-Methylgenistein | ChEBI | | 5,7-Dihydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one | ChEBI | | 5,7-Dihydroxy-3-p-methoxyphenyl-4H-chromen-4-one | ChEBI | | 5,7-Dihydroxy-4'-methoxyisoflavone | ChEBI | | Olmelin | ChEBI | | Pratensol | ChEBI | | Biochanin a, 14C-labeled | MeSH | | Genistein 4-methyl ether | MeSH | | 5,7-Dihydroxy-4'-methoxy-isoflavone | HMDB | | 5,7-Dihydroxy-4'-methoxy-isoflavone (8ci) | HMDB | | Biochanin | HMDB | | Biochanine a | HMDB | | 4'-Methoxy-5,7-dihydroxy isoflavone | biospider | | 4H-1-Benzopyran-4-one, 5, 7-dihydroxy-3-(4-methoxyphenyl)- | biospider | | 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(4-methoxyphenyl)- | biospider | | 5, 7-Dihydroxy-4'-methoxyisoflavone | biospider | | 5,7-dihydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one | biospider | | 5,7-Dihydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 9CI | db_source | | 5,7-dihydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one | biospider | | 5,7-dihydroxy-4'-methoxy-Isoflavone | biospider | | 5,7-dihydroxy-4'-methoxy-Isoflavone (8CI) | biospider | | Biochanin A | db_source | | Biochanin a (bca) | biospider | | biochanin A, 14C-labeled | biospider | | Biochanin-a | biospider | | Genistein 4'-methyl ether | db_source | | Isoflavone, 5,7-dihydroxy-4'-methoxy- | biospider | | Isoflavone, 5,7-dihydroxy-4'-methoxy- (8CI) | biospider | | QSO | biospider |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C16H12O5 |
|---|
| IUPAC name | 5,7-dihydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one |
|---|
| InChI Identifier | InChI=1S/C16H12O5/c1-20-11-4-2-9(3-5-11)12-8-21-14-7-10(17)6-13(18)15(14)16(12)19/h2-8,17-18H,1H3 |
|---|
| InChI Key | WUADCCWRTIWANL-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | COC1=CC=C(C=C1)C1=COC2=CC(O)=CC(O)=C2C1=O |
|---|
| Average Molecular Weight | 284.267 |
|---|
| Monoisotopic Molecular Weight | 284.068473486 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as 4'-o-methylisoflavones. These are isoflavones with methoxy groups attached to the C4' atom of the isoflavone backbone. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Isoflavonoids |
|---|
| Sub Class | O-methylated isoflavonoids |
|---|
| Direct Parent | 4'-O-methylisoflavones |
|---|
| Alternative Parents | |
|---|
| Substituents | - 4p-o-methylisoflavone
- Isoflavone
- Hydroxyisoflavonoid
- Chromone
- Benzopyran
- 1-benzopyran
- Anisole
- Phenoxy compound
- Phenol ether
- Methoxybenzene
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Pyranone
- Alkyl aryl ether
- Monocyclic benzene moiety
- Benzenoid
- Pyran
- Vinylogous acid
- Heteroaromatic compound
- Ether
- Organoheterocyclic compound
- Oxacycle
- Organooxygen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Environmental role: |
|---|
| Foods | Nuts and legumes: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 67.60%; H 4.25%; O 28.14% | DFC |
|---|
| Melting Point | Mp 215-216° | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | 336 (e 9000) (EtOH-NaOH) (Berdy) | DFC |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| GC-MS | Biochanin A, 2 TMS, GC-MS Spectrum | splash10-03di-2944800000-78e1196ce4a6b5cc510e | Spectrum | | GC-MS | Biochanin A, non-derivatized, GC-MS Spectrum | splash10-03di-2944800000-78e1196ce4a6b5cc510e | Spectrum | | GC-MS | Biochanin A, non-derivatized, GC-MS Spectrum | splash10-03di-1833900000-f09d96dccb297f00dcd5 | Spectrum | | Predicted GC-MS | Biochanin A, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0a4i-0490000000-c605105233a09c99c287 | Spectrum | | Predicted GC-MS | Biochanin A, 2 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-03k9-3439600000-64fa3b3cc333606e4699 | Spectrum | | Predicted GC-MS | Biochanin A, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - ESI-TOF 40V, Negative | splash10-014r-0190000000-7f6a864949fd18a14e8b | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 50V, Negative | splash10-03yr-0790000000-5a2ccc494db05b9e19e7 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 30V, Negative | splash10-014i-0090000000-1469c7dc6efca44dce49 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF , Negative | splash10-001i-0090000000-ab7e811e30dd92aa8de3 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 20V, Negative | splash10-001i-0090000000-ab7e811e30dd92aa8de3 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 40V, Negative | splash10-014r-0190000000-7f6a864949fd18a14e8b | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 50V, Negative | splash10-03yr-0790000000-5a2ccc494db05b9e19e7 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 30V, Negative | splash10-014i-0090000000-1469c7dc6efca44dce49 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF , Negative | splash10-001i-0090000000-ab7e811e30dd92aa8de3 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 20V, Negative | splash10-0159-0090000000-48950d676f0cb98a7321 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - DI-ESI-qTof , Positive | splash10-0w9c-0490000000-9f316916713e817996ee | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - DI-ESI-qTof , Positive | splash10-0a4i-0019000000-09139525e32bfa06cffd | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - DI-ESI-qTof , Negative | splash10-014i-0190000000-3d2d9ae76aea2ba8e0d4 | 2017-09-14 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000i-0090000000-47e7f5888047896fbeab | 2015-05-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-0090000000-0d44debd7dc24705b82a | 2015-05-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0udi-4970000000-62cdcc296c60a0b9a572 | 2015-05-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000i-0090000000-47e7f5888047896fbeab | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-0090000000-0d44debd7dc24705b82a | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0udi-4970000000-62cdcc296c60a0b9a572 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001i-0090000000-57c90dbeeae680583b28 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-001i-0090000000-cfc655e2b327c5f14670 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0ue9-3890000000-4aefff84d287041c16e9 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001i-0090000000-57c90dbeeae680583b28 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-001i-0090000000-cfc655e2b327c5f14670 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0ue9-3890000000-4aefff84d287041c16e9 | 2015-05-27 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 4444068 |
|---|
| ChEMBL ID | CHEMBL131921 |
|---|
| KEGG Compound ID | C00814 |
|---|
| Pubchem Compound ID | 5280373 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 17574 |
|---|
| Phenol-Explorer ID | 397 |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB02338 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | HFG01-K:HFG01-K |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | BIOCHANIN-A|BIOCHANIN |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00002510 |
|---|
| HET ID | QSO |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Biochanin_A |
|---|
| Phenol-Explorer Metabolite ID | 397 |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| 17-beta-hydroxysteroid-dehydrogenase inhibitor | 23924 | An agent that blocks the activity of 17-beta-hydroxysteroid dehydrogenase, an enzyme involved in steroid hormone biosynthesis. It has therapeutic applications in treating hormone-dependent cancers, such as breast and prostate cancer, by reducing estrogen and androgen production. | DUKE | | 5-alpha-reductase inhibitor | 50781 | An agent that blocks the conversion of testosterone to dihydrotestosterone, reducing androgenic effects. Therapeutically, it treats benign prostatic hyperplasia, androgenetic alopecia, and acne, by decreasing prostate size, promoting hair growth, and minimizing sebaceous gland activity. | DUKE | | Alpha-reductase inhibitor | 23924 | An agent that blocks the conversion of testosterone to dihydrotestosterone, reducing androgenic effects. Therapeutically, it treats conditions like benign prostatic hyperplasia, androgenetic alopecia, and acne, by decreasing sebum production and slowing hair loss. | DUKE | | Anti-alcoholic | 52217 | An agent that reduces alcohol cravings and withdrawal symptoms, commonly used in managing alcohol dependence and addiction, aiding in the treatment of alcohol use disorder by blocking the rewarding aspects of alcohol consumption. | DUKE | | Anti carcinogenic | 35610 | An agent that prevents or inhibits the formation of cancer, reducing tumor growth and proliferation. It plays a biological role in protecting cells from DNA damage and mutation. Therapeutically, it is used to prevent cancer development, with key medical applications in chemotherapy, radiation protection, and cancer prevention programs. | DUKE | | Anti cephalagic | 52217 | An agent that relieves headache symptoms, commonly used in managing migraines and other cephalalgias. Its biological role involves inhibiting pain pathways, and its therapeutic applications include reducing inflammation and alleviating vascular headaches, making it a key medical use in neurology and pain management. | DUKE | | Anti-mutagenic | | An agent that interferes with the mutagenicity of a substance, preventing DNA damage and mutations. Its biological role is to protect cells from genetic alterations, and it has therapeutic applications in cancer prevention and treatment, as well as key medical uses in reducing the risk of genetic disorders and birth defects. | DUKE | | Anti proliferant | | An agent that prevents or inhibits cell growth and division, used therapeutically to treat cancer, manage tumor growth, and prevent restenosis after angioplasty, reducing abnormal cell proliferation. | DUKE | | Anti prostat adenomic | 35610 | An agent that inhibits the growth of prostatic adenoma cells, reducing benign prostatic hyperplasia (BPH) symptoms. It helps alleviate urinary obstruction, improving quality of life for patients with enlarged prostates, and is used to treat BPH and prevent related complications. | DUKE | | Anti-prostatitic | | An agent that relieves prostatitis, reducing inflammation of the prostate gland, and is used to treat benign prostatic hyperplasia (BPH) and chronic pelvic pain syndrome. | DUKE | | Antitumor | 35610 | An agent that inhibits tumor growth and proliferation, playing a crucial role in cancer treatment. Therapeutically, antitumors are used to manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, helping to reduce tumor size, prevent metastasis, and improve patient outcomes. | DUKE | | Apoptotic | | An agent that stimulates programmed cell death, playing a crucial biological role in eliminating damaged or unwanted cells. It has therapeutic applications in cancer treatment, and key medical uses include inducing cell death in malignant cells, reducing tumor growth, and enhancing chemotherapy efficacy. | DUKE | | Aromatase inhibitor | 50790 | An agent that blocks the activity of aromatase, an enzyme converting androgens to estrogens, reducing estrogen levels. Therapeutically, it's used to treat hormone-sensitive breast cancer, endometriosis, and infertility, by decreasing estrogen-dependent growth and symptoms. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Chemopreventive | 35610 | An agent that prevents or delays the development of cancer, reducing the risk of tumor formation and progression. It plays a biological role in inhibiting carcinogenesis, and has therapeutic applications in cancer prevention, with key medical uses including reducing the risk of colorectal, breast, and prostate cancers. | DUKE | | Estrogen receptor beta binder | 50739 | An agent that binds to estrogen receptor beta, regulating gene expression and influencing various physiological processes. It has therapeutic applications in managing menopausal symptoms, osteoporosis, and certain cancers, with key medical uses including hormone replacement therapy and cancer treatment. | DUKE | | Estrogen agonist | 63951 | An agent that mimics the action of estrogen, regulating female reproductive and sexual health. Therapeutically, it's used to manage menopausal symptoms, osteoporosis, and certain reproductive disorders, promoting bone density and relieving symptoms associated with estrogen deficiency. | DUKE | | Estrogenic | | An agent that mimics the effects of estrogen, regulating female reproductive processes and development. Therapeutically, estrogenic agents are used in hormone replacement therapy, contraception, and treating menopausal symptoms, as well as certain cases of osteoporosis and infertility. | DUKE | | Flatulent | | A substance causing gas accumulation in the alimentary canal. Biologically, it aids in digestion. Therapeutically, it's used to relieve constipation and bloating. Medically, key uses include treating gastrointestinal disorders, such as irritable bowel syndrome, and preparing the bowel for surgical procedures or colonoscopies. | DUKE | | Fungicide | 24127 | An agent that kills or inhibits the growth of fungi, playing a biological role in preventing fungal infections. Therapeutically, it is used to treat fungal diseases, with key medical applications including athlete's foot, ringworm, and candidiasis, as well as agricultural uses to protect crops from fungal damage. | DUKE | | Fungistat | | An agent that inhibits fungal growth, used to prevent fungal infections, commonly applied in therapeutic applications such as treating skin and nail infections, and managing fungal diseases in immunocompromised patients. | DUKE | | Herbicide | 24527 | A chemical agent that kills or inhibits plant growth, used in agriculture to control weeds and pests. It has no direct biological role or therapeutic applications in human medicine, but its development has led to the creation of related compounds with potential medical uses, such as anticancer agents. | DUKE | | Hypocholesterolemic | | An agent that lowers cholesterol levels in the blood, playing a crucial role in preventing cardiovascular disease. Therapeutically, it is used to manage hyperlipidemia and reduce the risk of heart disease, with key medical applications including the treatment of high cholesterol, atherosclerosis, and coronary artery disease. | DUKE | | Hypolipidemic | | An agent that lowers lipid levels, treating hyperlipidemias by reducing cholesterol and triglyceride production, with therapeutic applications in managing cardiovascular disease, atherosclerosis, and stroke, commonly used to prevent heart attacks and improve overall cardiovascular health. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Topoisomerase-II inhibitor | 50750 | An agent that blocks the activity of topoisomerase-II, an enzyme involved in DNA replication. It prevents cancer cell growth by disrupting DNA structure, commonly used in chemotherapy to treat various types of cancer, including leukemia and lymphoma. | DUKE | | Topoisomerase-I inhibitor | 50276 | An agent that blocks the activity of topoisomerase I, an enzyme involved in DNA replication. It is used therapeutically in cancer treatment, particularly for solid tumors, by inducing DNA damage and inhibiting cancer cell growth, with key medical uses in colorectal, lung, and breast cancers. | DUKE | | Utero trophic | 52217 | A hormone that stimulates uterine growth and development, playing a crucial role in pregnancy. Therapeutically, it's used to support embryonic implantation and fetal development, with key medical applications in infertility treatments, such as in vitro fertilization (IVF) and recurrent miscarriage prevention. | DUKE | | VAM simulant | | A vasopressin receptor agonist that mimics the effects of vasopressin, stimulating water reabsorption in the kidneys. Therapeutically, it treats central diabetes insipidus, nocturia, and bleeding disorders by reducing urine production and increasing blood clotting factors. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Rothwell JA, Pérez-Jiménez J, Neveu V, Medina-Ramon A, M'Hiri N, Garcia Lobato P, Manach C, Knox K, Eisner R, Wishart D, Scalbert A. (2013) Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database, 10.1093/database/bat070. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|